The required share price to uplist to Nasdaq is $4. The price is determined by the bid price, not the closing price, of the stock. In April 2009, Nasdaq lowered its share price threshold to $4 from $5. This was presumably due to the impact that the financial crisis had on share prices, but could also be seen as a move to take some business from the Amex exchange. Both the Amex and the Nasdaq charge substantial listing fees to companies for listing on their exchanges and both are eager to maximize revenue. Amex has a lower required share price of $2 to $3 for an uplisting.
So how is this possible????? Another FUBAR moment in this Soap Opera????
I thought they were only "holding back" because of the lawsuit? You guys said once the lawsuit was over, you'd see more out of Rose and SIGA. Again, this stock will ALWAYS disappoint the longs because you have (1) an absolutely unqualified CEO and (2) a management that just doesn't care, period.
2 thumbs down already....but not one response on where all of the good news is that was bottle necked because they were holding it back due to the lawsuit. Been over for a while now....where's the beef??
"Been over for a while now"
7 days is a while Eh? It most definitely takes the Board more than Seven days to wipe its.....
Anyway, What you want is for them to magically pull out a bunch of great news less than one week after emerging, and after 10 yrs of trying to look as destitute and puny as possible. Would that Be smart??? Would that Pass the smell test?? Not that it matters to anyone anymore Except Us dwindling Bag holdders.
Oh I get it, Now you are dogging them for not doing the Dumb thing is that it???
Come on we have both been here long enough to know wanting, wishing, hopping, asking for news Does nothing to produce it.... Just when was the last Conference Call????? AUG 2014????
Drod, Why do you care anymore? Just Kicking us in the Testies while we are down out of spite?? Or have you Monetarily Got back in the Pit????
OH....got it! So now we're going off of the "BK emerge" date and not the date the actual final ruling came down?!?! You folks sure do know how to deflect whatever reality is don't you. It's almost like the people here need some serious therapy because they've falling into a world of illusion and they actually believe it!
by the way, why wouldn't it be smart to make some positive things happen now? Can PIP re-sue them?!?! Can't get any worse.
what would you consider good news?
here is a to do list for the management:
1. start paying (more than $5M) to PIP by finding financing for appx $90M-
2. do their best to advance through the FDA in order to continue the BARDA
contract execution. next parts are still the majority of the contract (money
3. advance other candidates - after years of little r&d, its time to dust off and
go to work. time to make the shareholders happy as opposed to making
the lawyers happy.
Ouch Drod.... Kicking them while they are down. News is coming, but i expect it is the dilution news. After that, it will be positive news over the next few months. They have an excellent product that is in demand. I think that demand will only grow both domestically and internationally, as no matter the outcome of the election, we will have the most uncertainty in the white house that we have had in decades. Given the business scope, uncertainty is a sales driver.
There she goes! Keep in mind that SIGA will NEVER miss an opportunity to completely disappoint it's investors. Follow the leader....has Rose bought ANY stock of the company of which he RUNS in the past 5 years??? That's the million $ question and answer.
No one every gave it to boomeriz straight, and they just followed him blindly.....kind of like they do Eric Rose, and the guy never came back to apologize. He just disappeared. So now someone has to be the brunt of their anger. I've never seen a more lost group of souls.
swear on anything that isn't me....but I honestly wish I had listened to him, I'd be a LOT wealthier right now. Sometimes we're better off listening to the ones we don't want to believe....
NEW YORK --(BUSINESS WIRE)-- SIGA Technologies, Inc a company specializing in the development of pharmaceutical agents to combat bio-warfare pathogens, announced today that it has begun enrolling the second and final cohort of healthy subjects for the Phase III clinical study for its lead drug candidate, TPOXX (tecovirimat), for the treatment of orthopoxvirus. This Phase III study, which is wholly funded the by the Biomedical Advanced Research and Development Authority (BARDA) will be conducted at eleven approved investigative sites with a total of approximately 360 subjects.
The initial Phase III lead cohort of 40 subjects in this trial has already completed participation without any reports of serious adverse events.
Screening of subjects for the second Phase III cohort initiated on April 11, 2016 , and the first subject was enrolled and dosed on April 18, 2016 . Since tecovirimat is being developed under the FDA "Animal Rule," there are no efficacy endpoints in this clinical trial. This study will generate safety and pharmacokinetic data in support of the prescribing information that will be part of the New Drug Application (NDA) filing.